Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are essentially the most maturely developed TPD tactics. In this particular evaluation, we focus on equally preclinical experiments and clinical trials to supply an extensive summary of the safety and medical effectiveness of PROTACs and MGDs in hematologic malignancies in the last https://roberts641jos4.blognody.com/profile